| CCC | A379 | 
| PubMed | 12727576 | 
| Wiki | Proinsulin | 
Proinsulin is synthesized in the pancreatic beta cells as a 9390 mw polypeptide of 86 amino acids. Proinsulin is subsequently cleaved enzymatically, releasing insulin into the circulation along with a residual 3000 mw fragment called C-peptide, so-named because it connects the A and B chains of insulin within the proinsulin molecule.
Proinsulin, which has relatively low biological activity (approximately 10% of insulin potency), is the major storage form of insulin. Normally, only small amounts (~3% of the amount of insulin, on a molar basis) of proinsulin enter the circulation. Because the hepatic clearance of proinsulin is only 25% of insulin clearance, the half-life of proinsulin is two- to threefold longer and concentrations in the fasting state are approximately 10% to 15% of insulin concentrations.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Proteins | RPA379Hu01 | Recombinant Proinsulin (PI) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| Antibodies | n/a | Monoclonal Antibody to Proinsulin (PI) | Monoclonal Antibody Customized Service Offer | 
| n/a | Polyclonal Antibody to Proinsulin (PI) | Polyclonal Antibody Customized Service Offer | |
| Assay Kits | CEA379Hu | ELISA Kit for Proinsulin (PI) | Enzyme-linked immunosorbent assay for Antigen Detection. |